With the rapid development of China's embodied AI industry, its technological dividends are increasingly being shared with the world.

On June 16, Malaysia's National Neuro-Robotic and Cybernics Rehabilitation Centre in the state of Perak was officially opened.

The centre, built by the Social Security Organisation of Malaysia (PERKESO), is one of the most advanced rehabilitation facilities in Southeast Asia.

As a key partner of PERKESO, Chinese robotics company Fourier was invited to showcase its GRx humanoid robot series at the opening event, highlighting the vast potential of embodied AI in clinical rehabilitation and patient care.  

"Our partnership with PERKESO was not built overnight. Rather, it has been a gradual journey of building trust since 2022, evolving from product application and research collaboration to joint project development," said Gu Jie, founder and CEO of Fourier. Today, the partnership enters a new chapter with the launch of one of the region's most cutting-edge rehabilitation facilities.

Designed to accommodate up to 700 patients at a time, the centre is built for scale and impact. Besides serving local patients, it will also serve as a global centre of excellence for PERKESO's Rehabilitation and Return to Work programs, setting a new international benchmark for technology-enabled recovery and workforce reintegration.

It features an expanded suite of Fourier's intelligent rehabilitation solutions, including its Galileo system—an advanced biomechanics analysis and rehabilitation platform—and its RehabHub devices, both deployed to support research and rehabilitation applications. The Galileo system commenced trial operations at the centre in October 2025 and has since benefited over 1,000 patients.

The centre's opening event offered a glimpse into the future of rehabilitation and clinical care through live humanoid demonstrations. The GRx showcased its capabilities in fitness routines, and its potential role in supporting occupational therapy in clinical research settings. Together, these applications highlighted the expanding role of humanoid robotics in patient care, with future possibilities spanning mobility assistance, ward patrols, and patient companionship.

Beyond deploying advanced rehabilitation technologies, Fourier and PERKESO have reaffirmed their shared commitment to innovation through collaborative R&D initiatives. They will invest in R&D across multiform robotics, embodied AI, and emerging rehabilitation technologies including brain-computer interfaces, functional electrical stimulation, and virtual reality.

"Embodied AI is still evolving rapidly. Our true aspiration is to work alongside global peers to drive the maturity of this technology within real-world scenarios," said Gu.